SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Denburg, S D
Right arrow Articles by Denburg, J A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denburg, S D
Right arrow Articles by Denburg, J A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus

S D Denburg

McMaster University, Hamilton, ON, Canada, denburgs{at}mcmaster.ca

J A Denburg

McMaster University, Hamilton, ON, Canada

Nervous system involvement in systemic lupus erythematosus (SLE) is typically diagnosed on the basis of clinical psychiatric and/or neurologic syndromes (NPSLE). Neuropsychologicaltests can be used to assess nervous system integrityeven in the absence of major NP syndromes. Their application has uncovered significant cognitive dysfunction, ranging from mild to severe, in a sizeable proportion of SLE patients irrespective of clinical NP status. Cognitive dysfunction has now been accepted as a bona fide manifestation of NPSLE. The heterogeneityof clinical NPSLE manifestations is paralleled by the diversity of cognitive deficits reported in different studies and within different patients. The success of attempts to explain these deficits on the basis of potentialpathogeneticmechanisms, such as antibrain antibodies and proinflammatory cytokines, has been uneven. To date, the most robust findings have emerged in relation to antiphospholipid antibodies, which carry with them important therapeutic implications.

Key Words: antiphospholipidantibodies • cognition • neuropsychology • systemic lupus erythematosus

Lupus, Vol. 12, No. 12, 883-890 (2003)
DOI: 10.1191/0961203303lu497oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PsychosomaticsHome page
H. Raza, S. A. Epstein, M. Pao, and D. L. Rosenstein
Mania: Psychiatric Manifestations of the Antiphospholipid Syndrome
Psychosomatics, September 1, 2008; 49(5): 438 - 441.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
J T Merrill
Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus
Lupus, November 1, 2004; 13(11): 869 - 876.
[Abstract] [PDF]


Home page
LupusHome page
N J Abbott, L L. Mendonca, and D E. Dolman
The blood-brain barrier in systemic lupus erythematosus
Lupus, December 1, 2003; 12(12): 908 - 915.
[Abstract] [PDF]



Advertisement